Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment Article

Zemanova, Lucie, Hofman, Jakub, Novotna, Eva et al. (2015). Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment . JOURNAL OF NATURAL PRODUCTS, 78(11), 2666-2674. 10.1021/acs.jnatprod.5b00616

cited authors

  • Zemanova, Lucie; Hofman, Jakub; Novotna, Eva; Musilek, Kamil; Lundova, Tereza; Havrankova, Jana; Hostalkova, Anna; Chlebek, Jakub; Cahlikova, Lucie; Wsol, Vladimir

sustainable development goals

authors

publication date

  • November 1, 2015

webpage

published in

keywords

  • ALDOSE REDUCTASE
  • CELLS
  • Chemistry, Medicinal
  • FAMILY 1 B10
  • HEPATOCELLULAR-CARCINOMA
  • ISOQUINOLINE ALKALOIDS
  • KETO REDUCTASE 1B10
  • Life Sciences & Biomedicine
  • PANCREATIC-CARCINOMA
  • Pharmacology & Pharmacy
  • Plant Sciences
  • SELECTIVE-INHIBITION
  • STRUCTURAL BASIS
  • Science & Technology
  • TUMOR-MARKER AKR1B10

Digital Object Identifier (DOI)

publisher

  • AMER CHEMICAL SOC

start page

  • 2666

end page

  • 2674

volume

  • 78

issue

  • 11